SCHEMBL17816135

SCHEMBL17816135

O=C(Nc1cc(F)c(F)c(F)c1)c1ccc(I)c(SC2CCC(C(=O)O)C2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 2/20 0.35
RARB P10826 2/20 0.35
RARG P13631 2/20 0.35
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
MAOB P27338 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
LMNA P02545 2/20 0.33
KCNQ3 O43525 2/20 0.33
KCNQ2 O43526 2/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
HTR1F P30939 1/20 0.32
KDM1A O60341 2/20 0.32
MAOA P21397 1/20 0.31
KCNE1 P15382 1/20 0.31
KCNQ1 P51787 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816134 0.94 RARA (0.36) RARARARBRARGTP53MAPT
SCHEMBL17816156 0.94 RARA (0.36) RARARARBRARGTP53MAPT
SCHEMBL17816078 0.94 RARA (0.36) RARARARBRARGTP53MAPT
SCHEMBL17816077 0.94 RARA (0.36) RARARARBRARGTP53MAPT
SCHEMBL17816136 0.91 NPC1 (0.44) MAOBNPC1RAB9ALMNAKCNQ3
SCHEMBL17784050 0.91 RARA (0.37) RARARARBRARGTP53MAPT
SCHEMBL17816122 0.86 NPC1 (0.47) MAPTMAOBNPC1RAB9AKCNQ3
SCHEMBL17816181 0.85 DGAT1 (0.34) RARARARBRARGTP53MAPT
SCHEMBL17816084 0.85 CYP1A2 (0.37) RARARARBRARGTP53MAPT
SCHEMBL17816080 0.85 MAPT (0.40) RARARARBRARGTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed